All O
patients O
were O
managed O
by O
an O
intensified O
protocol O
, O
including O
stringent O
glycemic T
control T

Down D
syndrome D
fetuses O
( O
41.7 O
% O
) O
had O
prenatally O
detected O
sonographic O
anomalies O
, O
63.6 O
% O
for O
Edward D
syndrome D
, O
and O
all O
fetuses O
with O
Patau D
syndrome D
( O
4 O
of O
4 O
) O
showed O
abnormal O
sonographic O
signs O

Signs O
observed O
in O
fetuses O
with O
trisomy D
13 D
were O
: O
hydrocephalus O
, O
intrauterine O
growth O
retardation O
, O
oligoanhydramnios O
, O
complex O
malformations O
, O
severe O
fetal O
bradycardia D
and O
hydronephrosis D

Right O
temporal O
and O
cerebellar O
hemorrhages O
were O
present O

Omphalocele-Exstrophy-Imperforate D
anus-Spinal D
defects D
( D
OEIS D
complex D
) D
, O
a O
combination O
of O
omphalocele D
, O
exstrophy D
of D
the D
bladder D
, O
an O
imperforate O
anus O
and O
spinal D
defects D
, O
arises O
from O
a O
single O
localized O
defect O
in O
the O
early O
development O
of O
the O
mesoderm O
that O
will O
later O
contribute O
to O
infraumbilical O
mesenchyme O
, O
cloacal O
septum O
, O
and O
caudal O
vertebrae O

In O
this O
report O
, O
we O
document O
the O
perinatal O
features O
of O
two O
cases O
of O
OEIS D
complex D
associated O
with O
meningomyeloceles D
and O
severe O
lower O
limb O
defects O
, O
and O
discuss O
the O
prenatal O
diagnosis O
, O
inheritance O
, O
and O
differential O
diagnosis O
of O
this O
association O
of O
malformations O

Both O
pregnancies O
were O
complicated O
by O
preterm O
labor O
and O
hypertension D

MAIN O
OUTCOME O
MEASURES O
: O
Linkage O
analysis O
results O
generated O
using O
both O
genetic O
model-dependent O
( O
lod O
score O
) O
and O
model-independent O
methods O

Chromosome O
12 O
gave O
the O
strongest O
and O
most O
consistent O
results O
with O
a O
peak O
multipoint O
MLS O
of O
3.5 O
, O
suggesting O
that O
this O
region O
contains O
a O
new O
susceptibility O
gene O
for O
AD O

CONTEXT O
: O
A O
mutation O
in O
the O
BRCA1 O
gene O
may O
confer O
substantial O
risk O
for O
breast O
and/or O
ovarian O
cancer D

The O
3 O
regions O
include O
HLA O
on O
chromosome O
6p21.3 O
, O
APOE O
on O
chromosome O
19ql O
3.2 O
, O
and O
MBP O
( O
myelin O
basic O
protein O
) O
on O
chromosome O
18q23 O

RESULTS O
: O
The O
HLA O
effect O
is O
due O
to O
the O
class O
II O
DR2 O
haplotype O
, O
DRB1*1501-DQA1*0102-DRB1*0602 O
; O
contributions O
to O
MS O
susceptibility O
from O
additional O
DRB1-DQB1 O
alleles O
or O
other O
HLA O
region O
loci O
were O
not O
observed O

< O
TO_SEE O
> O
OBJECTIVE O
: O
To O
examine O
long-term O
risk O
of O
new O
primary O
cancers O
in O
survivors O
of O
childhood O
retinoblastoma O
and O
quantify O
the O
role O
of O
radiotherapy O
in O
sarcoma O
development O

All O
114 O
sarcomas D
of O
diverse O
histologic O
types O
occurred O
in O
patients O
with O
hereditary O
retinoblastoma D

Demographic O
information O
, O
hours O
from O
rupture O
of O
membranes O
to O
delivery O
, O
gestational O
age O
, O
and O
birth O
weight O
at O
delivery O
were O
compared O
using O
Fisher O
's O
exact O
, O
Mann-Whitney O
U O
, O
and O
randomization O
tests O
where O
appropriate O

Over O
half O
thought O
HIV D
transmission O
occurred O
most O
times O
or O
always O

In O
the O
absence O
of O
structural O
or O
karyotypic O
abnormalities O
, O
spontaneous O
resolution O
of O
the O
effusion O
portends O
for O
a O
successful O
pregnancy O
outcome O

RESULTS O
: O
Results O
of O
first O
tune-up O
show O
an O
open O
set O
speech O
understanding O
in O
approximately O
50 O
% O
of O
patients O

CONCLUSIONS O
: O
In O
adults O
, O
open O
set O
speech O
understanding O
can O
be O
achieved O
even O
at O
the O
first O
tune-up O

Of O
the O
5 O
children O
with O
seizures D
, O
3 O
had O
an O
increase O
in O
attacks O
, O
whereas O
the O
other O
2 O
showed O
no O
change O
or O
a O
reduction O

An O
LRP O
was O
only O
observed O
on O
no-go O
trials O
when O
the O
semantic O
( O
not O
the O
phonological O
) O
decision O
determined O
the O
response O
hand O

BACKGROUND O
: O
Antiplatelet T
therapy T
with T
aspirin T
and T
systematic T
anticoagulation T
with T
warfarin T
reduce O
cardiovascular D
morbidity D
and D
mortality D
after D
myocardial D
infarction D
when O
given O
alone O

Primary O
comparisons O
were O
done O
with O
all O
follow-up O
data O

INTERPRETATION O
: O
Low O
, O
fixed-dose O
warfarin T
( T
1 T
mg T
or T
3 T
mg T
) T
combined T
with T
low-dose T
aspirin T
( T
80 T
mg T
) T
in O
patients O
who O
have O
had O
myocardial D
infarction D
does O
not O
provide O
clinical O
benefit O
beyond O
that O
achievable O
with O
160 O
mg O
aspirin T
monotherapy T

343 O
eligible O
patients O
were O
randomised O
: O
172 O
to O
surgery T
and O
171 O
to O
radical O
radiotherapy T

Nutritional O
assessment O
, O
substrate O
immunonutrition O
, O
and O
disease O
specific O
issues O
are O
presented O

A O
substantial O
fraction O
of O
the O
organic O
compounds O
on O
the O
early O
Earth O
may O
have O
been O
derived O
from O
comet O
and O
meteorite O
impacts O

The O
first O
step O
of O
purification O
of O
the O
effective O
signaling O
SCW O
components O
from O
both O
snail O
species O
was O
achieved O
by O
ion-exchange O
chromatography O

Twenty-four O
patients O
with O
cerebral D
palsy D
and O
24 O
control O
subjects O
between O
the O
ages O
of O
4 O
and O
12 O
yr O
were O
enrolled O
in O
this O
study O

When O
each O
group O
was O
divided O
into O
two O
additional O
subgroups O
based O
on O
the O
initial O
PI O
, O
it O
was O
found O
that O
ENS O
could O
reduce O
PI O
and O
increase O
PT O
significantly O
( O
P O
& O
# O
60 O
; O
0.05 O
) O
, O
but O
did O
not O
significantly O
( O
P O
> O
0.05 O
) O
improve O
ROM O
, O
as O
compared O
with O
the O
placebo O
group O
for O
both O
subgroups O

It O
could O
reduce O
PI O
significantly O
more O
( O
P O
& O
# O
60 O
; O
0.05 O
) O
than O
placebo O
controls O
only O
for O
the O
subgroup O
with O
mild O
to O
moderate O
pain O
, O
but O
not O
with O
severe O
pain O

Because O
activity O
and O
regular O
exercise O
are O
important O
factors O
to O
maintain O
general O
good O
health O
in O
senior O
citizens O
, O
we O
investigated O
whether O
senior O
dancing O
has O
any O
effect O
on O
peripheral O
or O
lumbar O
bone O
density O

Linear O
regression O
analysis O
showed O
that O
the O
lower O
the O
qCT O
at O
the O
beginning O
of O
the O
observation O
period O
, O
the O
higher O
was O
the O
percentage O
increase O
of O
spinal O
qCT O
in O
the O
entire O
group O
during O
12 O
mo O
of O
dancing O
( O
r O
= O
0.52 O
, O
P O
& O
# O
60 O
; O
0.0001 O
) O

Group O
I O
showed O
a O
significant O
correlation O
between O
basal O
spinal O
BMD O
and O
the O
percentage O
change O
of O
BMD O
during O
the O
observation O
period O
( O
r O
= O
0.7 O
, O
P O
& O
# O
60 O
; O
0.001 O
) O

Changes O
of O
the O
biochemical O
parameters O
were O
observed O
in O
the O
bone-specific O
isoenzyme O
of O
alkaline O
phosphatase O
, O
a O
marker O
of O
osteoblastic O
activity O
, O
in O
group O
I O
giving O
additional O
evidence O
of O
increased O
bone O
formation O

Prevalence O
on O
the O
basis O
of O
enzyme O
immunoassay O
was O
1.6 O
% O
( O
0.8 O
% O
to O
2.7 O
% O
) O
, O
with O
a O
sensitivity O
of O
60 O
% O
and O
a O
specificity O
of O
100 O
% O

However O
, O
in O
the O
first O
case O
, O
activation O
of O
apoptosis O
is O
blocked O
by O
the O
basal O
activity O
of O
p210 O
( O
BCR-ABL O
) O
, O
whereas O
in O
the O
second O
, O
the O
presence O
of O
p210 O
( O
BCR-ABL O
) O
appears O
to O
accelerate O
the O
onset O
of O
apoptosis O
by O
a O
mechanism O
that O
may O
involve O
an O
activation O
of O
its O
kinase O
function O

In O
11 O
out O
of O
12 O
normal O
healthy O
volunteers O
this O
task O
resulted O
in O
activation O
in O
posterior O
portions O
of O
the O
parahippocampal O
region O
, O
close O
to O
the O
collateral O
sulcus O

The O
authors O
suggest O
that O
changes O
in O
Ca2+ O
regulation O
could O
adjust O
the O
thresholds O
for O
synaptic O
modification O
, O
favoring O
processes O
for O
depression O
of O
synaptic O
strength O
during O
aging O

The O
Nb2 O
form O
, O
lacking O
198 O
aa O
in O
the O
cytoplasmic O
domain O
, O
is O
able O
to O
transmit O
a O
lactogenic O
signal O
similar O
to O
the O
long O
form O
, O
whereas O
the O
short O
form O
of O
291 O
aa O
is O
inactive O

Our O
results O
provide O
evidence O
that O
heterodimerization O
of O
receptors O
can O
be O
implicated O
either O
in O
the O
positive O
or O
in O
negative O
activation O
of O
gene O
transcription O

The O
sterilization O
and O
contaminated O
waste O
disposal O
practices O
in O
all O
14 O
dental O
clinics O
operated O
by O
the O
Southern O
Sydney O
Area O
Health O
Service O
were O
surveyed O

Misinterpretation O
of O
`` O
safe O
and O
adequate O
'' O
to O
mean O
`` O
safety O
limit O
'' O
would O
impose O
restrictions O
on O
vitamin O
and O
mineral O
intakes O
that O
are O
not O
needed O
to O
ensure O
safety O

Only O
the O
DSB O
model O
correctly O
predicted O
that O
PLD O
( O
= O
DSBs O
) O
would O
still O
be O
available O
for O
repair O
after O
that O
time O

SETTING O
: O
Three O
suburban O
public O
high O
schools O
in O
California O

INTERVENTION O
: O
After O
random O
assignment O
to O
1 O
of O
3 O
groups O
, O
the O
adolescents O
listened O
to O
a O
standardized O
audiotape O
depiction O
of O
an O
office O
visit O
during O
which O
they O
heard O
a O
physician O
who O
assured O
unconditional O
confidentiality O
, O
a O
physician O
who O
assured O
conditional O
confidentiality O
, O
or O
a O
physician O
who O
did O
not O
mention O
confidentiality O

RESULTS O
: O
Assurances O
of O
confidentiality O
increased O
the O
number O
of O
adolescents O
willing O
to O
disclose O
sensitive O
information O
about O
sexuality O
, O
substance O
use O
, O
and O
mental O
health O
from O
39 O
% O
( O
68/175 O
) O
to O
46.5 O
% O
( O
178/383 O
) O
( O
beta=.10 O
, O
P=.02 O
) O
and O
increased O
the O
number O
willing O
to O
seek O
future O
health O
care O
from O
53 O
% O
( O
93/175 O
) O
to O
67 O
% O
( O
259/386 O
) O
( O
beta=.17 O
, O
P O
& O
# O
60 O
; O
.001 O
) O

Neutrophils O
from O
the O
peripheral O
blood O
of O
these O
participants O
and O
from O
healthy O
controls O
were O
stimulated O
with O
opsonised O
zymosan O
, O
and O
superoxide O
production O
was O
measured O
by O
a O
spectrophotometric O
assay O
( O
reduction O
of O
ferricytochrome O
C O
) O

BACKGROUND O
: O
Accelerated T
infusion T
of T
alteplase T
( T
tissue T
plasminogen T
activator T
) T
over O
a O
period O
of O
90 O
minutes O
induces O
more O
rapid O
lysis O
of O
coronary-artery D
thrombi D
than O
a O
3-hour O
infusion O

The O
primary O
end O
point O
was O
death O
from O
any O
cause O
at O
30 O
days O

Therefore O
, O
accelerated T
infusion T
of T
alteplase T
over O
a O
period O
of O
90 O
minutes O
remains O
the O
preferred O
regimen O

The O
heart O
valves O
had O
a O
glistening O
white O
appearance O

Internal O
fixation O
was O
achieved O
with O
either O
dual O
intrameduilary O
threaded O
Steinmann O
pins O
or O
an O
obliquely O
placed O
AO O
compression O
screw O
and O
a O
three- O
or O
four-hole O
one-third O
tubular O
dorsal O
neutralization O
plate O

The O
average O
postoperative O
metatarsophalangeal O
dorsiflexion O
angle O
was O
15.6 O
degrees O
and O
the O
first O
metatarsophalangeal O
angle O
was O
3.1 O
degrees O

OBJECTIVE O
: O
To O
estimate O
the O
crude O
incidence O
rates O
of O
cerebrovascular D
accidents D
among O
the O
black O
residents O
of O
Harare O

Thirty-five O
per O
cent O
of O
patients O
died O
within O
1 O
week O
of O
the O
stroke O

CONCLUSION O
: O
With O
a O
standardised O
rate O
of O
68 O
per O
100000 O
and O
a O
first-week O
mortality O
rate O
of O
35 O
% O
, O
stroke D
must O
now O
be O
considered O
an O
important O
cause O
of O
morbidity O
and O
mortality O
in O
the O
population O

We O
find O
that O
CO2 O
is O
a O
true O
catalyst O
of O
the O
decomposition O
of O
peroxynitrite O
, O
and O
this O
fundamental O
insight O
into O
its O
action O
must O
be O
rationalized O
by O
any O
in O
vivo O
or O
in O
vitro O
reaction O
mechanism O
that O
is O
proposed O

The O
parthengenotes O
were O
derived O
only O
from O
eggs O
that O
failed O
to O
extrude O
polar O
bodies O
, O
mostly O
from O
eggs O
failing O
to O
extrude O
a O
second O
polar O
body O

Eggs O
derived O
from O
immature O
oocytes O
activated O
by O
A23187 O
, O
treated O
with O
1-MeAde T
and O
post-treated O
with O
cytochalasin T
B T
failed O
to O
extrude O
polar O
bodies O
, O
and O
eventually O
developed O
into O
parthenogenetic O
embryos O

The O
optical O
axis O
remained O
clear O
in O
the O
six O
eyes O
that O
had O
PC T
IOL T
implantation T
with O
vitrectomy T
( O
with O
or O
without O
posterior T
optic T
capture T
) O

OUTCOME O
MEASURES O
: O
Number O
and O
rate O
of O
patients O
making O
a O
first O
return O
with O
sore D
throat D
, O
pharyngitis D
, O
or O
tonsillitis D

There O
was O
no O
difference O
between O
groups O
in O
early O
return O
( O
13/238 O
( O
5.5 O
% O
) O
v O
27/437 O
( O
6 O
% O
) O
) O
, O
or O
complications O
( O
2/236 O
( O
0.8 O
% O
) O
v O
3/434 O
( O
0.7 O
% O
) O
) O

Both O
current O
and O
previous O
prescribing O
for O
sore D
throat D
increase O
reattendance O

Visual O
analog O
scales O
( O
VAS O
, O
0-100 O
mm O
) O
were O
used O
to O
assess O
pain O
and O
sedation O
at O
baseline O
; O
at O
3 O
, O
6 O
, O
9 O
, O
12 O
, O
15 O
, O
20 O
, O
25 O
, O
30 O
, O
45 O
, O
and O
60 O
min O
; O
and O
every O
30 O
min O
until O
further O
analgesia O
was O
requested O

The O
study O
was O
terminated O
at O
30 O
min O
if O
satisfactory O
analgesia O
was O
not O
achieved O

The O
50 O
% O
and O
95 O
% O
effective O
dose O
values O
for O
each O
opioid O
to O
achieve O
a O
VAS O
score O
& O
# O
60 O
; O
10 O
mm O
were O
F O
33 O
microg O
and O
92 O
microg O
and O
S O
6.7 O
microg O
and O
17.5 O
microg O

It O
resembles O
Crohn D
's D
disease D
clinically O
and O
radiologically O
, O
and O
it O
may O
be O
difficult O
to O
differentiate O
between O
them O
, O
even O
at O
laparotomy O
or O
histology O

< O
TO_SEE O
> O
Every O
effort O
must O
be O
made O
to O
exclude O
abdominal D
tuberculosis D
before O
the O
patient O
is O
diagnosed O
as O
having O
Crohn D
's D
disease D
and O
is O
treated O
with O
steroids T

The O
literature O
suggests O
higher O
complication O
rates O
when O
synthetic O
materials O
are O
used O
for O
slings T

However O
, O
in O
the O
panel O
's O
opinion O
retropubic T
suspensions T
and O
sling T
procedures T
are O
associated O
with O
slightly O
higher O
complication O
rates O
, O
including O
longer O
convalescence O
and O
postoperative D
voiding D
dysfunction D

This O
did O
not O
increase O
with O
an O
infusion O
of O
30 O
mcg/kg O
per O
min O
of O
dobutamine O
, O
which O
resulted O
in O
an O
increase O
in O
the O
cardiac O
output O
from O
1.96 O
to O
5.46 O
l/min O

pylori O
therapy O

Three O
cases O
of O
mild O
preeclampsia D
were O
found O
in O
the O
partner T
insemination T
program O
and O
nine O
cases O
of O
preeclampsia D
( O
five O
severe O
, O
four O
mild O
) O
in O
the O
donor T
insemination T
program O
( O
relative O
risk O
1.85 O
, O
95 O
% O
confidence O
interval O
1.20 O
to O
2.85 O
) O
. O

This O
supports O
, O
indirectly O
, O
an O
immunologic O
basis O
for O
preeclampsia D

The O
antigenic O
factor O
would O
appear O
to O
be O
located O
on O
the O
sperm O
as O
opposed O
to O
the O
seminal O
fluid O
itself O

METHODS O
& O
# O
38 O
; O
OUTCOME O
MEASURES O
: O
Toxicological O
screening O
using O
enzyme-linked O
immunoassay O
techniques O
, O
with O
all O
positive O
samples O
being O
reanalysed O

OBJECTIVE O
: O
To O
determine O
whether O
patients O
with O
myocardial D
amyloidosis D
due O
either O
to O
AL O
( O
primary O
) O
amyloid O
or O
familial O
amyloid O
have O
distinguishing O
echocardiographic O
or O
electrocardiographic O
features O
; O
and O
to O
compare O
the O
prevalence O
of O
heart D
failure D
and O
survival O
in O
the O
two O
types O
of O
amyloidosis D
in O
relation O
to O
echocardiographic O
findings O

SETTING O
: O
Two O
urban O
trauma O
centers O

In O
all O
cases O
a O
coproparasitological O
study O
was O
performed O

Statistical O
significant O
association O
was O
found O
between O
B O

Our O
findings O
suggest O
that O
breastfeeding O
may O
promote O
faster O
growth O
in O
infants O
compromised O
by O
poor O
growth O
in O
utero O

( O
5 O
) O
Future O
plans O
were O
either O
singular O
in O
focus O
or O
limited O
to O
maintenance O
of O
current O
health O
habits O

Clinical O
factors O
associated O
with O
a O
higher O
death O
rate O
were O
syncope D
( O
P=.012 O
) O
, O
arterial D
hypotension D
( O
P=.021 O
) O
, O
history O
of O
congestive D
heart D
failure D
( O
P=.013 O
) O
, O
and O
chronic D
pulmonary D
disease D
( O
P=.032 O
) O

Cerebral D
bleeding D
occurred O
in O
2 O
patients O
in O
each O
treatment O
group O
, O
and O
1 O
patient O
in O
each O
group O
died O
of O
a O
bleeding D
complication O

Subsequently O
, O
recurrence O
of O
pleural D
mesothelioma D
and O
peritoneal O
involvement O
by O
mesothelioma D
was O
documented O

The O
lesions O
were O
placed O
within O
1 O
mm O
of O
the O
ventral O
border O
of O
the O
globus O
pallidus O
internus O
( O
GPi O
) O
to O
include O
pallidothalamic O
outflow O
pathways O

Sequential O
MR O
studies O
were O
obtained O
within O
1 O
to O
3 O
days O
postoperatively O
and O
at O
6-month O
follow-up O
examination O

In O
two O
patients O
small O
ischemic D
infarctions D
involving O
the O
corona O
radiata O
were O
found O
, O
and O
in O
one O
a O
venous D
infarction D
was O
detected O

Magnetic O
resonance O
imaging O
analysis O
showed O
that O
intraoperative O
microelectrode O
recording O
facilitated O
accurate O
placement O
of O
the O
lesion O
in O
this O
critical O
area O

OBJECTIVE O
: O
We O
determined O
the O
sensitivity O
and O
specificity O
of O
neonatal O
brain-stem O
auditory O
evoked O
potentials O
( O
BAEP O
) O
as O
markers O
for O
subsequent O
hearing D
impairment D
and O
for O
developmental D
problems D
found O
later O
in O
infancy O
and O
childhood O

Most O
significantly O
, O
7 O
( O
58 O
% O
) O
of O
the O
12 O
children O
with O
subsequent O
sensorineural D
hearing D
loss D
had O
left O
the O
hospital O
after O
showing O
normal O
results O
on O
threshold O
tests O

BACKGROUND O
: O
Darier D
disease D
is O
an O
uncommon O
genodermatosis D
characterized O
by O
the O
symmetrical O
eruption O
of O
keratotic O
reddish-brown O
papules O
occurring O
in O
the O
seborrheic O
areas O
of O
the O
body O

This O
condition O
was O
aggravated O
by O
sunlight O
, O
heat O
, O
or O
sweating O
in O
42 O
% O
( O
19/40 O
) O
of O
reported O
cases O
, O
and O
38 O
% O
( O
15/40 O
) O
of O
the O
patients O
responded O
to O
treatment O
with O
topical O
tretinoin T

UV O
radiation O
induces O
two O
major O
DNA O
damage O
products O
, O
the O
cyclobutane O
pyrimidine O
dimer O
( O
CPD O
) O
and O
, O
at O
a O
lower O
frequency O
, O
the O
pyrimidine O
( O
6-4 O
) O
pyrimidinone O
dimer O
( O
6-4 O
product O
) O

In O
addition O
, O
we O
are O
able O
to O
generate O
plants O
in O
which O
only O
CPDs O
or O
6-4 O
products O
are O
photoreactivated O
in O
the O
nuclear O
genome O
by O
exposing O
these O
mutants O
to O
UV O
light O
and O
then O
allowing O
them O
to O
repair O
one O
or O
the O
other O
class O
of O
dimers O

The O
serum O
cytokine O
profile O
during O
the O
acute O
phase O
of O
her O
illness O
showed O
high O
levels O
of O
tumor O
necrosis O
factor-alpha O
, O
interleukin-6 O
and O
interferon-gamma O
, O
as O
is O
seen O
during O
activation O
of O
the O
immune O
system O
by O
TSS D
toxin O
1 O

Other O
possible O
causes O
for O
the O
patient O
's O
illness O
were O
excluded O

This O
clinical O
scenario O
must O
be O
differentiated O
from O
that O
in O
which O
germ D
cell D
tumors D
maintain O
their O
malignant O
characteristics O
with O
elevated O
levels O
of O
serum O
tumor O
markers O

BACKGROUND O
: O
We O
assessed O
the O
accuracy O
of O
two O
electron O
beam O
computed O
tomography O
( O
EBCT O
) O
protocols O
for O
predicting O
coronary D
events D

Calcium O
quantities O
calculated O
for O
both O
protocols O
, O
performed O
on O
the O
same O
subjects O
, O
were O
sorted O
in O
ascending O
order O
and O
divided O
into O
equal O
quartiles O

The O
very O
motivation O
for O
seeking O
an O
`` O
origin O
'' O
of O
homosexuality O
reveals O
homophobia O

The O
negative O
predictive O
value O
of O
high O
serum O
follicle O
stimulating O
hormone O
( O
FSH O
) O
concentrations O
( O
> O
or O
=10 O
IU/l O
) O
( O
predicting O
failure O
to O
find O
spermatozoa O
for O
ICSI O
) O
was O
low O
( O
38.4 O
% O
) O

Although O
the O
observed O
break O
points O
in O
the O
BCL-1 O
locus O
are O
not O
tightly O
clustered O
, O
its O
rearrangement O
has O
been O
documented O
in O
40-70 O
% O
of O
cases O
of O
mantle D
cell D
lymphoma D
, O
whereas O
it O
only O
rarely O
occurs O
in O
other O
B D
cell D
lymphomas D

In O
contrast O
to O
known O
bHLH O
genes O
, O
detectable O
transcription O
of O
SHARP O
genes O
begins O
at O
the O
end O
of O
embryonic O
development O
marking O
differentiated O
neurons O
that O
have O
reached O
a O
final O
position O
, O
and O
increases O
as O
postnatal O
development O
proceeds O

Similarly O
, O
within O
1 O
h O
after O
the O
administration O
of O
kainic O
acid O
in O
vivo O
, O
SHARP-2 O
is O
induced O
in O
neurons O
throughout O
the O
rat O
cerebral O
cortex O

The O
embryonic O
development O
of O
the O
face O
has O
been O
studied O
in O
many O
reviews O
, O
this O
work O
purposes O
only O
to O
clear O
up O
some O
points O
which O
remain O
obscure O
concerning O
cervico-facial O
morphogenesis O

This O
phenomenon O
raises O
different O
questions O
, O
in O
particular O
about O
the O
relation O
of O
this O
disposition O
with O
the O
nasoseptal O
center O
, O
the O
medial O
part O
of O
the O
nasodorsal O
center O

A O
discriminant O
score O
of O
> O
or O
= O
275 O
indicated O
a O
> O
or O
= O
90 O
% O
probability O
of O
preeclampsia D

Residual O
resist O
was O
stripped O
with O
acetone O

Fluorescent O
imaging O
demonstrated O
smallest O
line O
widths O
of O
2-3 O
microns O

Treated O
fibres O
are O
incubated O
with O
the O
patient O
serum O
for O
10 O
min O
followed O
by O
incubation O
with O
goat O
anti O
human O
IgG O
tagged O
FITC O

Also O
, O
no O
false O
positive O
result O
was O
obtained O
with O
serum O
samples O
of O
patients O
infected O
with O
leprosy D
, O
tuberculosis D
, O
typhoid D
and O
malaria D
, O
showing O
the O
specificity O
of O
the O
sensor O
and O
efficacy O
of O
the O
technique O

These O
biosensors O
are O
fabricated O
by O
site-selective O
photodeposition O
of O
analyte-sensitive O
polymer O
matrices O
on O
optical O
imaging O
fibres O

The O
characterization O
of O
low O
molecular O
weight O
ligand O
interaction O
with O
receptor O
molecules O
is O
of O
importance O
for O
the O
investigation O
of O
biological O
processes O
and O
for O
drug O
research O

We O
report O
on O
the O
investigation O
of O
the O
binding O
of O
low O
molecular O
weight O
ligands O
to O
immobilized O
receptors O
by O
label-free O
detection O

High O
affinity O
binding O
of O
biotin O
to O
immobilized O
streptavidin O
was O
clearly O
detectable O
at O
receptor O
surface O
concentrations O
as O
low O
as O
1-2 O
x O
10 O
( O
10 O
) O
binding O
sites/mm2 O

Gamma-irradiation O
( O
25 O
kGy O
) O
is O
suitable O
for O
the O
sterilization O
procedure O

The O
final O
lactate O
catheter O
is O
characterized O
by O
a O
linear O
concentration O
range O
between O
0.5 O
and O
20 O
mmol/l O
lactate O
with O
a O
sensitivity O
around O
2 O
nA O
mmol-1 O
l-1 O
lactate O

Also O
, O
the O
magnitude O
of O
the O
changes O
in O
the O
binding O
rate O
coefficients O
( O
k1 O
and O
k2 O
) O
and O
in O
the O
fractal O
dimensions O
( O
Df1 O
and O
Df2 O
) O
as O
different O
parameters O
are O
changed O
for O
the O
different O
biosensor O
applications O
are O
of O
particular O
value O
, O
since O
they O
provide O
us O
with O
a O
measure O
or O
extent O
of O
changes O
in O
the O
binding O
rate O
coefficient O
on O
changing O
different O
experimental O
parameter O
values O

In O
the O
tissue-culture O
medium O
, O
within O
a O
few O
seconds O
following O
microinjection O
, O
all O
tested O
dyes O
passed O
through O
the O
intercellular O
bridges O
in O
both O
the O
anterior O
direction O
( O
to O
the O
nurse O
cells O
) O
and O
the O
posterior O
direction O
( O
to O
the O
oocyte O
) O
, O
independent O
of O
their O
electrical O
charge O
or O
molecular O
mass O

The O
protein O
was O
found O
on O
a O
subset O
of O
axons O
in O
the O
central O
and O
peripheral O
nervous O
system O
and O
is O
likely O
to O
be O
involved O
in O
specific O
cell-cell O
interactions O
in O
neurohistogenesis O

Two O
different O
responses O
to O
the O
therapy O
were O
observed O
in O
a O
group O
of O
patients O
receiving O
the O
protease T
inhibitor T
indinavir T

In O
the O
second O
group O
, O
a O
rebound O
in O
virus O
levels O
in O
plasma O
followed O
the O
initial O
sharp O
decline O
observed O
at O
the O
start O
of O
therapy O

In O
one O
patient O
, O
a O
second O
mutation O
occurred O
at O
the O
gag O
p1/p6 O
cleavage O
site O
, O
but O
it O
appeared O
18 O
weeks O
after O
the O
time O
of O
appearance O
of O
the O
p7/p1 O
mutation O

Recombinant O
HIV-1 O
variants O
containing O
two O
or O
three O
mutations O
in O
the O
protease O
gene O
were O
constructed O
either O
with O
mutations O
at O
the O
p7/p1 O
cleavage O
site O
or O
with O
wild-type O
( O
WT O
) O
gag O
sequences O

This O
is O
the O
first O
report O
of O
the O
emergence O
of O
mutations O
in O
the O
gag O
p7/p1 O
protease O
cleavage O
sites O
in O
patients O
receiving O
protease T
therapy T
and O
identifies O
this O
change O
as O
an O
important O
determinant O
of O
HIV-1 O
resistance O
to O
protease O
inhibitors O
in O
patient O
populations O

The O
cDNA O
was O
expressed O
in O
Escherichia O
coli O
using O
the O
pGEX O
vector O
, O
and O
a O
recombinant O
fusion O
protein O
( O
EgCaBP1-GST O
) O
was O
obtained O

The O
possible O
role O
of O
this O
protein O
and O
that O
of O
the O
calcareous O
corpuscles O
in O
the O
protoscolex O
are O
discussed O

The O
induction O
of O
HMGI-C O
mRNA O
level O
is O
sensitive O
to O
both O
the O
protein O
synthesis O
inhibitor O
cycloheximide O
and O
transcription O
inhibitor O
actinomycin O
D O

We O
report O
the O
cDNA O
cloning O
, O
partial O
genomic O
organization O
, O
and O
expression O
pattern O
of O
Stra10 O
, O
a O
novel O
retinoic O
acid-inducible O
gene O
in O
P19 O
embryonal D
carcinoma D
cells O

The O
Meis2 O
homeodomain O
is O
identical O
to O
that O
of O
Meis1 O
, O
and O
is O
most O
closely O
related O
to O
those O
of O
the O
Pbx/TGIF O
homeobox O
gene O
products O

By O
in O
situ O
hybridization O
analysis O
, O
we O
show O
that O
the O
Meis2 O
gene O
displays O
spatially O
restricted O
expression O
patterns O
in O
the O
developing O
nervous O
system O
, O
limbs O
, O
face O
, O
and O
in O
various O
viscera O

The O
indoor O
pollution O
, O
where O
the O
patients O
pass O
in O
general O
close O
to O
90 O
% O
of O
their O
time O
, O
is O
an O
important O
factor O
to O
take O
in O
consideration O
if O
one O
wants O
to O
evaluate O
suitably O
the O
effects O
of O
the O
air O
pollution O
on O
the O
health O

The O
search O
of O
solutions O
needs O
multiple O
competences O
from O
the O
physician O
, O
who O
has O
to O
play O
an O
essential O
role O

The O
lipophilic O
character O
of O
dioxins O
prevents O
their O
excretion O
in O
the O
urine O
and O
causes O
their O
accumulation O
in O
body O
fat O

The O
mechanisms O
of O
dioxin O
action O
are O
similar O
to O
those O
of O
a O
hormone O

Chronic O
exposure O
of O
female O
Rhesus O
monkeys O
increases O
the O
incidence O
and O
severity O
of O
endometriosis D

These O
last O
drugs O
seem O
very O
attractive O
because O
they O
decrease O
insulin O
resistance O
in O
obese O
, O
diabetics O

Better O
knowledge O
of O
non O
lipidic O
effects O
of O
statins O
on O
the O
arterial O
wall O
and O
the O
discovery O
of O
the O
action O
of O
fibrates O
on O
PPAR O
( O
Peroxisome O
Proliferator O
Activated O
Receptors O
) O
improved O
strongly O
the O
therapeutic O
management O
of O
hyperlipidemias D

Randomized O
prospective O
studies O
have O
, O
however O
, O
never O
been O
able O
to O
confirm O
these O
observations O

Beyond O
a O
certain O
intensity O
of O
exercise O
, O
and O
coinciding O
with O
the O
accumulation O
of O
blood O
lactate O
( O
anaerobic O
threshold O
or O
AT O
) O
, O
a O
'saliva O
threshold O
' O
( O
Tsa O
) O
does O
indeed O
exist O

On O
the O
other O
hand O
, O
the O
mechanism O
for O
FFA O
transport O
from O
its O
storage O
as O
triglycerides O
in O
adipose O
tissue O
and O
muscle O
to O
its O
place O
of O
utilisation O
in O
heart O
, O
skeletal O
muscle O
, O
kidney O
and O
liver O
is O
more O
clearly O
understood O

Furthermore O
, O
it O
is O
widely O
documented O
that O
endurance O
activities O
increase O
the O
energy O
utilisation O
from O
fat O
while O
sparing O
carbohydrate O
sources O

Even O
after O
correction O
, O
8 O
out O
of O
11 O
methods O
still O
remained O
of O
little O
practical O
use O
because O
of O
their O
large O
relative O
errors O

One O
hundred O
and O
twenty-seven O
departments O
responded O
to O
a O
questionnaire O
sent O
in O
March O
1996 O

Social O
class O
and O
premarital O
sexual O
permissiveness O
: O
a O
re-examination O

Technical O
note O
on O
two O
rates O
of O
mixed O
marriage O

Courtship O
behaviour O
in O
the O
Drosophila O
obscura O
group O

Comparative O
studies O

The O
display O
of O
information O
and O
the O
judgment O
of O
contingency O

Amylase O
production O
by O
Streptomyces O
species O

A O
method O
to O
aid O
correct O
diagnosis O

Further O
data O
on O
mediastinal D
and D
pulmonary D
tumors D
of O
the O
child O

The O
relationship O
to O
fatty O
acids O

Conflict O
and O
conditioned O
aversive O
stimuli O
in O
the O
development O
of O
experimental O
neuroses O

Study O
of O
the O
effect O
of O
newer O
analeptic O
( O
Micoren O
) O
in O
hypoventilation O
syndrome O

Intra-arterial O
infusion O
of O
the O
head O
and O
neck O

Fetal O
chondrodystrophy O

Toxemia D
of O
pregnancy O

2 O
students O
at O
Quo O
Vadis O

Beta-propiolactone T
as O
used O
in O
sterilization O
of O
homografts O
not O
carcinogenic O
for O
mice O

Effect O
of O
epinephrine O
on O
myocardial O
triglyceride O
and O
free O
fatty O
acid O
utilization O

Fine O
structure O
of O
desmosomes O

Comparative O
fates O
of O
intravenously O
and O
orally O
administered O
aldosterone O
: O
evidence O
for O
extrahepatic O
formation O
of O
acid-hydrolyzable O
conjugate O
in O
man O

Clinical O
staging O
in O
cancer D
of D
the D
larynx D
: O
a O
report O
on O
788 O
cases O
using O
the O
American O
Joint O
Committee O
's O
method O
of O
stage O
classification O

Cardiac O
monitors O
work O
-- O
but O
they O
should O
report O
more O
than O
they O
do O

A O
pediatrician O
's O
checklist O
for O
adolescents O

Studies O
in O
infantile D
malnutrition D

Mutation O
frequencies O
detected O
following O
irradiation T
of O
virgin O
and O
inseminated O
Drosophila O
melanogaster O
females O

Oxytocin O
induction O
in O
pregnant O
rabbits O
, O
with O
special O
reference O
to O
the O
stillbirth O
rate O

Significance O
of O
a O
single O
umbilical O
artery O

Hypertrophic O
obstructive O
cardiomyopathy D

I O
. O
Effects O
of O
radiation O
on O
physical O
and O
chemical O
properties O
of O
injection O
needles O

XIX O

3 O

On O
the O
examination O
of O
ginseng O
and O
powdered O
ginseng O
in O
1969 O

Hydrogen O
ion O
equilibrium O
in O
heart D
failure D

Research O
on O
breeding O
hygiene O
in O
pigs O
and O
piglets O
free O
from O
epidemic D
diseases D

Gas O
permeability O
of O
plastic O
membranes O
for O
artificial T
lungs T

Cesarean O
deliveries O
at O
a O
university O
hospital O
: O
analysis O
of O
rates O
and O
indications O

Pregnancy O
in O
chronic O
progressive O
external O
ophthalmoplegia D
: O
a O
case O
report O

Laerdal O
infant O
resuscitators O
are O
unreliable O
as O
free-flow O
oxygen O
delivery O
devices O

Technical O
Working O
Group O
, O
World O
Health O
Organization O

Simultaneous O
measurement O
of O
stiffness O
and O
energy O
absorptive O
properties O
of O
articular O
cartilage O
and O
subchondral O
trabecular O
bone O

An O
analysis O
of O
34 O
cases O

Are O
the O
products O
of O
CD44 O
exons O
v5 O
and O
v6 O
markers O
for O
metastasis O
of O
laryngeal D
carcinomas D
? O

Detection O
of O
differentially O
expressed O
genes O
in O
head-neck D
carcinomas D

A O
'normal O
' O
practice O

Predisposition O
genetic O
testing O
for O
late-onset D
disorders D
in O
adults O

> O
From O
the O
Centers O
for O
Disease O
Control O
and O
Prevention O

Social O
ties O
and O
susceptibility O
to O
the O
common D
cold D

Prescribing O
protease T
inhibitors T
for O
the O
homeless O

Treatment O
of O
verruca D
vulgaris D
with O
topical T
cidofovir T

Complete O
genomic O
screen O
in O
late-onset O
familial O
Alzheimer D
disease D

Evidence O
of O
a O
new O
susceptibility O
locus O
in O
Caucasian O
and O
Chinese O
patients O

Cancer D
incidence O
after O
retinoblastoma D

Early O
and O
long-term O
results O
of O
rehabilitation O
of O
cochlear T
implant T
patients O
) O

Osteopathic O
manifesto O

The O
roots O

Treatment O
uncertainties O
surround O
early O
diagnosis O
of O
breast D
cancer D

Depression D
in O
the O
chronically O
ill O
needs O
separate O
treatment O

Osteopathic O
manifesto O

Heart D
disease D
: O
women O
's O
unique O
risks O
demand O
attention O

Resolution O
due O
in O
medical O
software O
regulation O

Another O
use O
of O
androgens T
: O
treatment O
of O
anemia D
of D
end-stage D
renal D
disease D

The O
American O
Medical O
Association O
Guidelines O
for O
Adolescent O
Preventive O
Services O

GPs O
' O
perceptions O
of O
tolerability O
of O
selective O
serotonin O
reuptake O
inhibitors O
and O
tricyclic O
antidepressants T

Authors O
' O
reply O

New O
authorship O
practices O
are O
needed O
in O
developing O
countries O

Cyclosporiasis D
and O
raspberries O

Agonist O
efficacy O
and O
allosteric O
models O
of O
receptor O
action O

Receptor O
Classification O
: O
The O
Integration O
of O
Operational O
, O
Structural O
, O
and O
Transductional O
Information O

An O
open O
future O

Joint O
Commission O
on O
Accreditation O
of O
Healthcare O
Organizations O
' O
infection O
control O
requirements O
: O
fact O
or O
fiction O
? O

Ethics O
of O
HIV O
trials O

Ethical O
issues O
in O
interventional T
radiology T

The O
role O
of O
procedures O
in O
family O
practice O
: O
is O
there O
a O
right O
answer O
? O

Update O
: O
influenza D
activity O
-- O
worldwide O
, O
March-August O
1997 O

Water O
fluoridation O
, O
tooth D
decay D
in O
5 O
year O
olds O
, O
and O
social O
deprivation O
measured O
by O
the O
Jarman O
score O
: O
analysis O
of O
data O
from O
British O
dental O
surveys O

The O
functional O
neuroanatomy O
of O
episodic O
memory O
retrieval O

Reattendance O
and O
complications O
in O
a O
randomised O
trial O
of O
prescribing O
strategies O
for O
sore O
throat O
: O
the O
medicalising O
effect O
of O
prescribing O
antibiotics O

Case O
records O
of O
the O
Massachusetts O
General O
Hospital O

< O
TO_SEE O
> O
Increased O
incidence O
of O
preeclampsia D
in O
women O
conceiving O
by O
intrauterine T
insemination T
with T
donor T
versus T
partner T
sperm T
for O
treatment O
of O
primary D
infertility D

A O
classification O
of O
nucleotide-diphospho-sugar O
glycosyltransferases O
based O
on O
amino O
acid O
sequence O
similarities O

Recombinant O
human O
DNase O
( O
rhDNase O
) O
influences O
phospholipid O
composition O
, O
surface O
activity O
, O
rheology O
and O
consecutively O
clearance O
indices O
of O
cystic D
fibrosis D
sputum O

Lumbar D
puncture D
need O
n't O
be O
a O
headache O

Atomic O
legacy O
in O
the O
Marshall O
Islands O

Role O
of O
free O
radicals O
, O
telomeres O
, O
and O
telomerases O
in O
aging O
and O
cancerogenesis O

schizophrenia D
as O
failure O
of O
hemispheric O
dominance O
for O
language O

< O
TO_SEE O
> O
Hepatic O
glutamine O
synthetase O
deficiency O
in O
fatal O
hyperammonemia O
after O
lung O
transplantation O

GAPS O
( O
AMA O
Guidelines O
for O
Adolescent O
Preventive O
Services O
) O

What O
investigations O
and O
procedures O
do O
patients O
in O
hospices O
want O
? O
Interview O
based O
survey O
of O
patients O
and O
their O
nurses O

Management O
of O
life-threatening O
acid-base D
disorders D

Second O
of O
two O
parts O

Rate O
of O
RhD O
sensitisation O
before O
and O
after O
implementation O
of O
a O
community O
based O
antenatal O
prophylaxis O
programme O

Mutations O
of O
the O
Drosophila O
dDP O
, O
dE2F O
, O
and O
cyclin O
E O
genes O
reveal O
distinct O
roles O
for O
the O
E2F-DP O
transcription O
factor O
and O
cyclin O
E O
during O
the O
G1-S O
transition O

SYT-SSX O
gene O
fusion O
as O
a O
determinant O
of O
morphology O
and O
prognosis O
in O
synovial O
sarcoma O

Genetic O
testing O
for O
cancer D
risk O
: O
how O
to O
reconcile O
the O
conflicts O

The O
AACC O
Lectureship O
Award O
Address O

Toxic D
shock D
syndrome D
without O
rash D
in O
a O
young O
child O
: O
link O
with O
syndrome O
of O
hemorrhagic D
shock D
and O
encephalopathy D
? O

Mediastinal O
growing O
teratoma D
syndrome D

Electron O
beam O
computed O
tomographic O
coronary O
calcium O
as O
a O
predictor O
of O
coronary O
events O
: O
comparison O
of O
two O
protocols O

Complementary O
and O
alternative O
medicine O
: O
friend O
, O
foe O
, O
or O
OWA O
? O

Small D
cell D
lung D
cancer D
can O
express O
CD34 O
antigen O

Analgesic D
nephropathy D

Variation O
in O
proficiency O
testing O
performance O
by O
testing O
site O

Lyme D
disease D
presenting O
as O
Tourette D
's D
syndrome D

Further O
evidence O
for O
the O
importance O
of O
an O
androgen O
response O
element O
in O
the O
factor O
IX O
promoter O

The O
use O
of O
implantable O
venous O
access O
devices O
( O
IVADs O
) O
in O
children O
with O
hemophilia D

Risk O
factors O
for O
HIV-1 D
infection D
among O
pregnant O
women O
in O
French O
Guiana O

Sequence O
analysis O
of O
the O
36-kb O
region O
between O
gntZ O
and O
trnY O
genes O
of O
Bacillus O
subtilis O
genome O

hordei O
glyceraldehyde-3-phosphate O
dehydrogenase O
gene O

March O
14-17 O
, O
1996 O

Psychobiology O
of O
Postraumatic D
Stress D
Disorder D

Proceedings O
of O
the O
VIIIth O
International O
Conference O
on O
the O
Na/K-ATPase O
and O
Related O
Transport O
ATPases O

Characterization O
of O
the O
orf31-petG O
gene O
cluster O
from O
the O
plastid O
genome O
of O
Populus O
deltoides O

Proceedings O
of O
the O
12th O
annual O
general O
meeting O

Abstracts O

3rd O
Neurotrauma/Polytrauma O
Symposium O

Saliva O
composition O
and O
exercise O

An O
overview O

Academic O
medicine O
and O
complementary O
medicine O
-- O
campaign O
for O
the O
truth O
in O
medical O
theories O

The O
academic O
medicine O
-- O
alternative O
medicine O
tension O
field O

Factor D
VII D
deficiency D

Two O
cases O

Cytokines O
and O
peripheral O
neuropathies O

Pneumosinus O
dilatans O
: O
a O
little-known O
diagnostic O
tool O

The O
radiological O
investigation O
of O
suspected O
lower O
limb O
deep D
vein D
thrombosis D

The O
Preterm O
Prediction O
Study O
: O
association O
of O
cesarean T
delivery T
with O
increases O
in O
maternal O
weight O
and O
body O
mass O
index O

Magnetic O
resonance O
imaging O
of O
the O
bone O
marrow O
in O
hematologic D
malignancies D

Generation O
of O
diversity O
in O
mammalian O
gut-associated O
lymphoid O
tissues O
: O
restricted O
V O
gene O
usage O
does O
not O
preclude O
complex O
V O
gene O
organization O

Genomic O
sequence O
of O
a O
Lyme D
disease D
spirochaete O
, O
Borrelia O
burgdorferi O

Interaction O
between O
electronic O
article O
surveillance O
systems O
and O
implantable O
defibrillators O
: O
insights O
from O
a O
fourth O
generation O
ICD O

Proposals O
for O
action O
by O
individuals O
and O
the O
Catholic O
Church O

Invited O
commentary O
: O
le O
myst√®re O
de O
Montr√ O
( O
c O
) O
al O
. O

A O
national O
survey O
of O
physician-assisted O
suicide O
and O
euthanasia O
in O
the O
United O
States O

An O
ecologic O
analysis O
of O
psychosocial D
stress D
and O
heart D
disease D
in O
British O
Columbia O

Spontaneous D
ovarian D
hyperstimulation D
syndrome D
with O
pregnancy O

Providing O
primary O
care O
in O
the O
accident O
and O
emergency O
department O

The O
first O
year O
of O
consultation O

Factors O
involved O
in O
the O
rate O
of O
fall O
of O
thyroid O
stimulating O
hormone O
in O
treated O
hypothyroidism D

Early O
identification O
of O
variant O
Creutzfeldt-Jakob D
disease D

Hemodynamic O
effects O
of O
acute O
tetrandrine O
and O
terlipressin O
administration O
on O
portal O
hypertensive O
rats O

Munchausen D
's D
syndrome D

Development O
of O
neurosurgery T
in O
Greece O
: O
past O
, O
present O
, O
and O
future O

Comparison O
of O
two O
methods O
in O
657 O
newborns O

Mike O
Grace O
talks O
to O
Mike O
Joy O

Chemotherapy T
alone T
compared O
with O
chemotherapy T
plus T
radiotherapy T
for O
localized O
intermediate- O
and O
high-grade O
non-Hodgkin D
's D
lymphoma D

A O
specialist O
nurse O
can O
replace O
pre-registration O
house O
officers O
in O
the O
surgical O
pre-admission O
clinic O

Cerebral D
infarct D
following O
central T
venous T
cannulation T

Relation O
between O
intellectual D
dysfunctioning D
and O
mortality O
in O
community-residing O
older O
people O

Gorlin D
syndrome D
: O
identification O
of O
4 O
novel O
germ-line O
mutations O
of O
the O
human O
patched O
( O
PTCH O
) O
gene O

Mutations O
in O
brief O
no O

Genetic O
findings O
in O
congenital D
bilateral D
aplasia D
of O
vas O
deferens O
patients O
and O
identification O
of O
six O
novel O
mutatations O

139 O

141 O

144 O

Online O

Purification O
and O
characterization O
of O
an O
acetyl O
xylan O
esterase O
from O
Bacillus O
pumilus O

Chromosome O
22qII O
deletions O

An O
under-recognised O
cause O
of O
idiopathic D
learning D
disability D

Successful O
replantation O
of O
an O
amputated O
tongue O

Identification O
of O
five O
new O
mutations O
and O
three O
novel O
polymorphisms O
in O
the O
muscle O
chloride O
channel O
gene O
( O
CLCN1 O
) O
in O
20 O
Italian O
patients O
with O
dominant O
and O
recessive O
myotonia D
congenita D

A O
novel O
missense O
mutation O
Ile538Val O
in O
the O
fibroblast O
growth O
factor O
receptor O
3 O
in O
hypochondroplasia D

Independent O
occurrence O
of O
the O
novel O
Arg2163 O
to O
His O
mutation O
in O
the O
factor O
VIII O
gene O
in O
three O
unrelated O
families O
with O
haemophila D
A D
with O
different O
phenotypes O

126 O

Bolstering O
Sisyphus O

Hormone T
replacement T
therapy T
and O
breast D
cancer D
. O

Linear D
lichen D
planopilaris D
of O
the O
face O

Death O
in O
springtime O

Acute D
obstructive D
hydrocephalus D
complicating O
bacterial D
meningitis D
in O
childhood O

Effect O
of O
protein O
kinase O
C O
inhibitors O
on O
cardioprotection O
by O
ischemic O
preconditioning O
depends O
on O
the O
number O
of O
preconditioning O
episodes O

Normoxic T
cardiopulmonary T
bypass T
reduces O
oxidative D
myocardial D
damage D
and D
nitric D
oxide D
during O
cardiac O
operations O
in O
the O
adult O

conclusion O
: O
as O
expected O
, O
the O
type O
of O
chemotherapy T
we O
used O
, O
to O
treat O
non-seminomatous D
germ-cell D
tumors D
proved O
to O
be O
highly O
effective O
for O
seminomatous D
types D
, O
as O
well O

our O
conclusion O
was O
that O
the O
covered-ems T
can O
be O
effective O
for O
the O
palliation O
of O
esophagorespiratory D
fistulas D

the O
food O
and O
drug O
administration O
( O
fda O
) O
recently O
approved O
the O
first O
protein-polysaccharide T
conjugate T
vaccine T
to O
prevent O
invasive D
pneumococcal D
diseases D
in O
infants O
and O
toddlers O
< O
2 O
years O
of O
age O

among O
these O
, O
the O
gemcitabine/cisplatin T
study O
protocol O
( O
gc O
) O
, O
set O
up O
in O
a O
phase O
ii O
study O
for O
patients O
with O
stage D
iiia D
n2 D
nsclc D
, O
was O
very O
effective O
( O
objective O
response O
( O
or O
) O
: O
70.2 O
% O
; O
median O
survival O
: O
19 O
months O
) O
and O
should O
be O
promising O
for O
stages O
ib O
and O
ii O

the O
cancer O
and O
leukemia O
group O
b O
performed O
a O
series O
of O
studies O
involving O
sequential T
chemotherapy T
followed T
by T
radiation T
for O
patients O
with O
unresectable D
stage D
iii D
nsclc D

purpose O
: O
many O
patients O
with O
locally D
advanced D
non-small-cell D
lung D
cancer D
( D
la-nsclc D
) D
are O
eligible O
for O
combined-modality T
therapy T
( T
cmt T
; T
chemotherapy T
and T
radiotherapy T
) T

urpose O
: O
to O
assess O
results O
with O
twice-daily O
high-dose O
radiotherapy T
( T
rt T
) T
for O
non-small-cell D
lung D
cancer D
( D
nsclc D
) D

conclusions O
: O
for O
patients O
with O
both O
esophageal D
and D
tracheobronchial D
stenoses D
, O
a O
stent T
should O
be O
introduced O
into O
the O
tracheobronchus O
first O

because O
placement O
of O
stents O
in O
both O
the O
esophagus O
and O
tracheobronchus O
has O
a O
high O
risk O
of O
enlargement O
of O
the O
fistula O
, O
a O
covered T
metallic T
stent T
is O
preferable O
for O
esophageal D
cancer D
involving D
the D
tracheobronchus D

setting O
: O
the O
nursing O
center O
himawari O
design O
, O
patient O
, O
and O
preparation O
: O
the O
regular O
dosage O
of O
nyt T
( O
15 O
g/d O
) O
was O
prescribed O
for O
7 O
weeks O
to O
one O
elderly O
patient O
with O
lung D
carcinoma D

methods O
: O
the O
cost O
of O
surgical T
treatment T
in O
1997 O
and O
1998 O
for O
patients O
with O
resectable D
primary D
or D
metastatic D
lung D
carcinoma D
was O
analyzed O
from O
itemized O
statements O
of O
hospital O
charges O

we O
reviewed O
our O
vats O
experience O
for O
therapeutic T
metastasectomy T
of O
peripheral D
colorectal D
pulmonary D
metastases D

methods O
: O
over O
90 O
months O
, O
therapeutic T
vats T
metastasectomy T
was O
accomplished O
upon O
80 O
patients O
with O
colorectal D
metastases D

conclusions O
: O
both O
the O
response O
rate O
and O
survival O
data O
in O
this O
retrospective O
study O
suggest O
a O
high O
degree O
of O
activity O
of O
this O
combination T
chemotherapy T
in O
patients O
with O
brain D
metastases D
from D
nsclc D

promising O
results O
have O
also O
been O
found O
with O
oxaliplatin T
in O
patients O
with O
non-hodgkin D
's D
lymphoma D
, D
breast D
cancer D
, D
mesothelioma D
and D
non-small D
cell D
lung D
cancer D

standard O
treatment O
of O
sclc D
consists O
of O
platinum-based T
combination T
chemotherapy T
, O
with O
thoracic O
irradiation O
added O
for O
patients O
with O
limited-stage O
disease O

objective O
: O
several O
reports O
emphasize O
the O
importance O
of O
en-bloc T
resection T
as O
the O
optimal O
surgical O
treatment O
of O
lung D
cancer D
with O
chest O
wall O
invasion O

a O
growing O
body O
of O
evidence O
suggests O
that O
postoperative T
irradiation T
for O
non-small D
cell D
lung D
cancer D
may O
cause O
life-threatening O
toxicity O
and O
, O
when O
the O
risk O
of O
local-regional O
recurrence O
is O
low O
, O
the O
toxicity O
of O
irradiation O
may O
outweight O
the O
benefit O

novel O
treatment O
strategies O
for O
patients O
with O
advanced D
nsclc D
may O
involve O
chemotherapy T
combined O
with O
inhibition O
of O
nf-kappab-dependent O
cell-survival O
pathways O

a O
phase O
ii O
study O
of O
irinotecan T
in T
combination T
with T
cisplatin T
( T
platinol T
) T
resulted O
in O
a O
response O
rate O
of O
86 O
% O
and O
a O
median O
survival O
of O
13.0 O
months O
in O
patients O
with O
extensive-disease D
small-cell D
lung D
cancer D

standard O
operations O
for O
lung D
cancer D
patients O
are O
generally O
accepted O
as O
performing O
lobectomy T
or T
pneumonectomy T
on O
the O
tumor O
baring O
lung O
and O
ipsilateral O
hilar O
and O
mediastinal O
lymphadenectomy O
including O
subcarinal O
lymph O
nodes O

for O
intrathoracic D
relapse D
and D
severe D
obstruction D
of D
main D
bronchus D
and/or D
superior D
caval D
vein D
, O
radiotherapy T
is O
a O
possibility O
if O
not O
given O
as O
part O
of O
first-line O
treatment O

sample O
: O
45 O
adults O
with O
primary O
cancer D
of D
the D
lung D
receiving O
< O
outpatient O
primary O
or O
adjuvant O
radiation T
therapy T

conclusion O
: O
pc T
is O
equally O
efficacious O
as O
vc T
for O
the O
treatment O
of O
advanced D
non D
-- D
small-cell D
lung D
cancer D

Continuous T
arterio-venous T
hemofiltration T
in O
a O
wearable O
device O
to O
treat O
end-stage D
renal D
disease D

Active T
forms T
of T
vitamin T
D3 T
, T
1 T
alpha-hydroxyvitamin T
D3 T
and T
1 T
alpha T
, T
25-dihydroxyvitamin T
D3 T
, O
were O
administered O
in O
an O
open-design O
study O
to O
40 O
patients O
with O
psoriasis D
vulgaris D
in O
three O
ways O
: O
to O
17 O
patients O
1 O
alpha-hydroxyvitamin O
D3 O
was O
given O
orally O
at O
a O
dose O
of O
1.0 O
micrograms/day O
for O
6 O
months O
, O
to O
four O
patients O
1 O
alpha O
, O
25-dihydroxyvitamin O
D3 O
was O
given O
orally O
at O
a O
dose O
of O
0.5 O
microgram/day O
for O
6 O
months O
, O
and O
19 O
patients O
were O
given O
1 O
alpha O
, O
25-dihydroxyvitamin O
D3 O
applied O
topically O
at O
concentration O
of O
0.5 O
microgram/g O
of O
base O
for O
8 O
weeks O

These O
data O
suggest O
that O
psoriasis D
may O
respond O
to O
active T
metabolites T
of T
vitamin T
D3 T
and O
that O
abnormalities O
in O
vitamin O
D O
metabolism O
or O
in O
responsiveness O
of O
the O
skin O
cells O
to O
active O
metabolites O
of O
vitamin O
D O
may O
be O
involved O
in O
the O
pathogenesis O
of O
this O
skin O
disease O

Over O
a O
1-year O
period O
, O
rigid T
ureteroscopy T
has O
been O
used O
to O
retrieve O
ureteric D
calculi D
in O
120 O
patients O

Recombinant T
leukocyte T
A T
interferon T
( T
rIFN-alpha T
A T
) T
in O
the O
treatment O
of O
disseminated D
malignant D
melanoma D

Two O
patients O
with O
metastatic D
dysgerminoma D
of D
the D
ovary D
were O
treated O
with O
a T
combination T
of T
etoposide T
, T
bleomycin T
, T
and T
cisplatin T
at O
The O
University O
of O
Texas O
M.D O

Guiding O
surgical T
therapy T
of O
ventricular D
tachycardia D
by O
preoperative O
endocardial O
catheter O
mapping O
necessitates O
improvement O
of O
the O
accuracy O
of O
localization O
of O
the O
arrhythmogenic O
site O

At O
6 O
months O
follow-up O
26 O
% O
( O
14/53 O
) O
of O
all O
the O
patients O
who O
underwent O
angioplasty T
had O
recurrence O
of O
angina D
, O
which O
was O
successfully O
treated O
with O
repeat T
angioplasty T
, T
bypass T
surgery T
, T
or T
medical T
therapy T

A O
comparison O
of O
a O
five-day O
regimen O
of O
cefdinir T
with O
a O
seven-day O
regimen O
of O
loracarbef T
for O
the O
treatment O
of O
acute O
exacerbations O
of O
chronic D
bronchitis D

The O
PR O
was O
observed O
in O
one O
patient O
with O
non-functioning D
endocrine D
pancreatic D
tumor D
with D
progressive D
liver D
and D
lymph D
node D
metastases D
after O
16 O
months O
of O
i.m T
. T
lanreotide T
therapy T

Traditionally O
, O
the O
therapy O
of O
symptomatic D
bronchiectasis D
is O
based O
on O
antibiotics T
, T
antibronchoobstructive T
medication T
, T
and T
chest T
physical T
therapy T

Surgical T
treatment T
is O
a O
good O
alternative O
for O
patients O
with O
persistent D
severe D
regurgitation D
during O
medical O
therapy O
and O
for O
young O
patients O
who O
prefer O
surgery O
to O
lifelong O
medication O

The O
surgical T
treatment T
of O
lung D
lacerations D
and D
major D
bronchial D
disruptions D
caused O
by O
blunt O
thoracic O
trauma O

CONCLUSIONS O
: O
Biliary D
dyskinesia D
patients O
who O
underwent O
cholecystectomy T
had O
significantly O
greater O
symptom O
improvement O
compared O
with O
nonsurgical O
patients O

Effectiveness O
of O
pseudoephedrine T
plus T
acetaminophen T
for O
treatment O
of O
symptoms O
attributed O
to O
the O
paranasal O
sinuses O
associated O
with O
the O
common D
cold D

We O
assessed O
the O
prevalence O
of O
head O
louse O
infestation O
and O
the O
effectiveness O
of O
1 T
% T
permethrin T
against O
head D
lice D
in O
Kosovar O
refugees O

PURPOSE O
: O
Macrolide T
antibiotics T
are O
frequently O
prescribed O
to O
patients O
with O
symptoms D
of D
a D
common D
cold D

Because O
the O
symptoms O
of O
rhinovirus O
colds O
are O
attributed O
to O
the O
inflammatory O
response O
to O
infection O
, O
we O
studied O
the O
effects O
of O
treatment O
with O
clarithromycin T
on O
the O
symptomatic O
and O
inflammatory O
response O
to O
nasal O
inoculation O
with O
rhinovirus D

In O
conclusion O
, O
in O
some O
cases O
of O
MDR D
TB D
, O
the O
TP T
( O
if O
there O
are O
no O
pleural O
adherences O
) O
may O
lead O
to O
good O
results O

Acupuncture T
treatment O
of O
common D
cold D

When O
bleeding D
is O
stopped O
via O
surgical T
or T
radiological T
methods T
, O
the O
clinical O
course O
of O
hemobilia-associated O
pancreatitis O
appears O
to O
be O
benign O

A O
field O
study O
was O
carried O
out O
to O
evaluate O
the O
effect O
of O
vaccination T
against O
swine D
enzootic D
pneumonia D
in O
different O
production O
systems O
( O
closed O
or O
one-site O
, O
and O
open O
, O
two- O
or O
three-site O
, O
systems O
) O

CONCLUSIONS O
: O
we O
found O
no O
evidence O
of O
disturbances O
in O
gastric O
remnant O
emptying O
after O
Roux-en-Y T
gastrojejunostomy T
to O
treat O
postoperative D
alkaline D
gastric D
reflux D

A O
three-step O
treatment O
algorithm O
for O
refractory D
AOM D
that O
employs O
amoxicillin T
, T
trimethoprim/sulfamethoxazole T
( T
TMP/SMX T
) T
, T
or T
high-dose T
amoxicillin/clavulanate T
( T
depending T
on T
the T
prior T
dose T
of T
and T
adherence T
to T
amoxicillin T
therapy T
) T
, T
and T
ceftriaxone T
or T
tympanocentesis T
at O
steps O
1 O
, O
2 O
, O
and O
3 O
, O
respectively O
, O
appears O
rational O
and O
cost-effective O

Sida T
cordifolia T
L. T
( T
Malvaceae T
) T
is O
used O
in O
folk O
medicine O
for O
the O
treatment O
of O
inflammation D
of D
the D
oral D
mucosa D
, D
blenorrhea D
, D
asthmatic D
bronchitis D
and D
nasal D
congestion D

OBJECTIVE O
: O
To O
evaluate O
the O
efficacy O
of O
oral T
tacrolimus T
as O
an O
induction O
agent O
in O
steroid-refractory D
severe D
colitis D
.Study O
design O
: O
Open-label O
, O
multicenter O
trial O
of O
oral O
tacrolimus O
in O
patients O
with O
severe O
colitis O

We O
assessed O
the O
effects O
of O
early T
replacement T
therapy T
with T
protein-C T
concentrate T
together T
with T
continuous T
veno-venous T
haemodiafiltration T
and O
conventional O
treatment O
in O
meningococcaemia D

We O
observed O
the O
effects O
of O
cisapride T
in O
the O
management O
of O
idiopathic D
constipation D
in O
children O

Touch O
sensibility O
was O
assessed O
with O
von O
Frey O
's O
monofilaments O
in O
the O
breasts O
of O
10 O
healthy O
women O
( O
controls O
) O
and O
of O
80 O
women O
with O
breast D
cancer D
who O
at O
least O
1 O
year O
previously O
had O
undergone O
subcutaneous T
mastectomy T
and O
immediate O
reconstruction O
with O
a O
prosthesis O

Consequently O
, O
parenteral T
nutrition T
( T
PN T
) T
solutions T
used O
to O
treat O
malnourished O
patients O
with O
chronic D
renal D
failure D
usually O
are O
prepared O
with O
little O
supplementation O
of O
these O
cations O

BACKGROUND O
: O
The O
growing O
use O
of O
heparin T
in O
acute D
thrombotic D
disorders D
, O
coupled O
with O
the O
availability O
of O
many O
new O
antithrombotic T
agents T
, O
emphasizes O
the O
need O
for O
adequate O
characterization O
of O
the O
platelet O
effects O
of O
the O
various O
anticoagulants T

Therefore O
, O
prudent O
management O
and O
use O
of O
washed T
red T
blood T
cells T
transfusion T
would O
prevent O
hemolytic D
aggravation D
even O
in O
open O
heart O
surgery O

We O
describe O
a O
technique O
that O
enables O
the O
autologous T
repair T
of O
large D
midline D
incisional D
hernias D
by O
restoring O
the O
functional O
musculoaponeurotic O
support O
of O
the O
abdominal O
wall O

< O
TO_SEE O
> O
As O
concomitant D
thrombocytosis D
persisted O
despite O
treatment O
with O
hydroxyurea T
, O
the O
new O
megakaryocyte T
inhibitor T
anagrelide T
( T
Agrelin T
) T
was O
administered O
and O
led O
to O
normalization O
of O
the O
platelet O
count O
within O
11 O
days O

Background O
: O
Troglitazone T
is O
a O
new O
drug O
for O
the O
treatment O
of O
type D
2 D
diabetes D

More O
than O
1600 O
patients O
with O
neoplastic D
disorders D
have O
received O
recombinant T
human T
interferon T
alfa-2a T
( T
Roferon-A T
, T
Hoffmann-La T
Roche T
, T
Nutley T
, T
NJ T
) T
as O
part O
of O
ongoing O
or O
completed O
clinical O
trials O

CONCLUSION O
: O
Omega3 T
fatty T
acids T
were O
well O
tolerated O
and O
improved O
the O
short-term O
course O
of O
illness O
in O
this O
preliminary O
study O
of O
patients O
with O
bipolar D
disorder D

The O
clinical O
application O
of O
therapeutic T
hysteroscopy T
, O
mainly O
in O
the O
field O
of O
the O
treatment O
of O
abnormal D
uterine D
bleeding D
, O
started O
in O
the O
1980s O

Understanding O
the O
culture O
of O
prescribing O
: O
qualitative O
study O
of O
general O
practitioners O
' O
and O
patients O
' O
perceptions O
of O
antibiotics T
for O
sore D
throats D

Steroid T
delivery T
in O
croup D

Haematoma T
block T
versus O
intravenous T
regional T
anaesthesia T
in O
Colles D
' D
fractures D

Endoscopic T
excision T
of O
a D
forehead D
mass D

Is O
there O
a O
rational O
therapy O
for O
symptomatic O
treatment O
of O
benign D
prostatic D
hyperplasia D
with O
phytogenic T
drugs T
? O
Illustrated O
with O
the O
example O
of O
the O
prostate O
agent O
from O
Serenoa O
repens O
( O
Sabal O
fructus O
) O

Prognostic O
factors O
in O
patients O
with O
locally O
advanced O
rectal D
adenocarcinoma D
treated O
with O
preoperative T
radiotherapy T
and O
surgery T

Sliding T
door T
technique T
for O
the O
repair O
of O
midline D
incisional D
hernias D

One-lung T
ventilation T
in O
patients O
with O
difficult D
airways D

Interferon T
treatment T
of O
renal D
cell D
carcinoma D

The O
effect O
of O
heliox T
in O
acute D
severe D
asthma D
: O
a O
randomized O
controlled O
trial O
. O

Long-term O
survival O
of O
patients O
with O
unresectable D
colorectal D
cancer D
liver D
metastases D
following O
infusional T
chemotherapy T
with T
5-fluorouracil T
, T
leucovorin T
, T
oxaliplatin T
and T
surgery T

IPPB T
in O
severe D
pulmonary D
emphysema D
: O
limited O
applications O

Surgical T
treatment T
of O
uterine D
cervix D
insufficiency D
during O
the O
2d O
trimester O
of O
pregnancy O

Phenylbutazone T
and O
acute D
leukemia D
. O

Dosing O
of O
amoxicillin/clavulanate T
for O
treatment O
of O
lower D
respiratory D
tract D
infection D

Long-term O
safety O
and O
effectiveness O
of O
iron-chelation T
therapy T
with T
deferiprone T
for O
thalassemia D
major D

Steroids T
in O
De D
Quervain D
's D
tenosynovitis D

Low-dose T
clozapine T
for O
the O
treatment O
of O
drug-induced D
psychosis D
in D
Parkinson D
's D
disease D

Comparing O
the O
efficacy O
and O
safety O
of O
fluoxetine T
and O
venlafaxine T
in O
outpatient D
depression D

Immunogenicity O
of O
three O
Haemophilus D
influenzae D
type D
b D
protein O
conjugate O
vaccines T
in O
HIV O
seropositive O
adults O
and O
analysis O
of O
predictors O
of O
vaccine O
response O

Phase O
1 O
safety O
and O
immune O
response O
studies O
of O
a O
DNA T
vaccine T
encoding O
hepatitis D
B D
surface O
antigen O
delivered O
by O
a O
gene O
delivery O
device O

Randomized O
phase O
II O
study O
of O
the O
neurokinin T
1 T
receptor T
antagonist T
CJ-11 T
, T
974 T
in O
the O
control O
of O
cisplatin-induced D
emesis D

NICE O
to O
rule O
on O
influenza D
flu D
drug O
zanamivir T

Gene T
therapy T
for O
cancer D

`` T
Tandem T
'' T
high-dose T
chemoradiotherapy T
with T
autologous T
stem-cell T
support T
in O
the O
treatment O
of O
newly O
diagnosed O
or O
responsive O
multiple D
myeloma D

